Arvinas, Inc. (ARVN) financial statements (2022 and earlier)

Company profile

Business Address 395 WINCHESTER AVE
NEW HAVEN, CT 06511
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,503689281188
Cash and cash equivalents10858893
Short-term investments1,394100272185
Restricted cash and investments5   
Receivables26865
Other undisclosed current assets20643
Total current assets:1,553703291196
Noncurrent Assets
Operating lease, right-of-use asset422
Property, plant and equipment131284
Deposits noncurrent assets   0
Other noncurrent assets 00 
Other undisclosed noncurrent assets13   
Total noncurrent assets:2914114
TOTAL ASSETS:1,582717302199
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5426127
Accounts payable31753
Accrued liabilities231984
Deferred revenue2062220
Debt  10
Contract with customer, liability16
Other undisclosed current liabilities11  
Total current liabilities:262493323
Noncurrent Liabilities
Long-term debt and lease obligation4342
Long-term debt, excluding current maturities1222
Operating lease, liability312
Liabilities, other than long-term debt534233838
Deferred revenue5342338
Contract with customer, liability37
Other liabilities   0
Total noncurrent liabilities:538264240
Total liabilities:800757563
Stockholders' equity
Stockholders' equity attributable to parent782642227137
Common stock 000
Additional paid in capital1,4691,134599439
Accumulated other comprehensive income (loss)(5)10(0)
Accumulated deficit(683)(492)(373)(302)
Total stockholders' equity:782642227137
TOTAL LIABILITIES AND EQUITY:1,582717302199

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues47224314
Gross profit:47224314
Operating expenses(242)(147)(95)(58)
Operating loss:(195)(125)(52)(44)
Nonoperating income4662
Investment income, nonoperating2452
Other nonoperating income3210
Interest and debt expense(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(191)(119)(46)(42)
Loss from equity method investments  (25) 
Loss before gain (loss) on sale of properties:(191)(119)(70)(42)
Other undisclosed net income0000
Net loss attributable to parent:(191)(119)(70)(41)
Preferred stock dividends and other adjustments   (198)
Net loss available to common stockholders, diluted:(191)(119)(70)(240)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(191)(119)(70)(41)
Comprehensive loss:(191)(119)(70)(41)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(5)00(0)
Comprehensive loss, net of tax, attributable to parent:(196)(119)(70)(42)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: